Clinical trials recruiting in Santa Ana, Costa Rica
3
Recruiting trials
7
Conditions
Phase breakdown
Phase 3 3
Conditions recruiting in Santa Ana, Costa Rica
| Condition | Trials |
|---|---|
| Breast Neoplasms | 1 |
| Breast cancer | 1 |
| Carcinoma, Non-Small Cell Lung | 1 |
| Lung cancer | 1 |
| Metastatic Castration-resistant Prostate Cancer (mCRPC) | 1 |
| Prostate cancer | 1 |
| Prostatic Neoplasms | 1 |
Recruiting trials in Santa Ana, Costa Rica
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Common questions
How many clinical trials are recruiting in Santa Ana, Costa Rica?
3 recruiting trials have at least one study site in Santa Ana, Costa Rica.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.